170 Long acting therapy of viral retinitis with HPMPC

Marisa Flores-Aguilar; JS Huang; BD. Kuppermman; Chau Vuong; D Munguia; CA. Wiley; De Clercq Erik; Kerry Assil; W.R. Freeman

doi:10.1016/0166-3542(93)90548-w

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1994

Long-Acting Therapy of Viral Retinitis with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl) cytosine

Marisa Flores Aguilar, Jiun‐Yan Huang, G. A. Wiley, De Clercq Erik, C Vuong, G Bergeron-Lynn, Becky Chandler, D Munguia, William R. Freeman

Article1996

Liposome-Encapsulated (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)cytosine for Long-Acting Therapy of Viral Retinitis

Baruch D. Kuppermann, Kerry K. Assil, C Vuong, Gilberto Besen, Clayton A. Wiley, De Clercq Erik, Germaine Bergeron-Lynn, James D. Connor, Michael Pursley, David Munguia, William R. Freeman

Article1996

Low dose intravitreal HPMPC (CIDOFOVIR) therapy for CMV retinitis in patients with aids

İbrahim Taşkintuna, Firas M. Rahhal, J. Fernando Arévalo, D Munguia, Alay Banker, De Clercq Erik, William R. Freeman

Article1997

Low-dose Intravitreal Cidofovir (HPMPC) Therapy of Cytomegalovirus Retinitis in Patients with Acquired Immune Deficiency Syndrome

İbrahim Taşkintuna, Firas M. Rahhal, J. Fernando Arévalo, David Munguia, Alay Banker, De Clercq Erik, William R. Freeman

Article1995

Intravitreal Cidofovir (HPMPC) Treatment of Cytomegalovirus Retinitis in Patients with Acquired Immune Deficiency Syndrome

L S Kirsch, J. Fernando Arévalo, Eugenio Chavez de la Paz, D Munguia, De Clercq Erik, William R. Freeman